35 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
interviews, inquiry of the person or persons making the recommendation or nomination, engagement of an outside search firm to gather additional information …
The hiring, engagement and retention of a skilled workforce is particularly important in the highly competitive scientific fields in which we operate. Our
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL … during such time); and (ii) the period (if any) during which Participant may exercise the Option after such termination of Participant’s engagement
8-K
EX-99.1
ATHA
Athira Pharma Inc
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
and continued engagement with U.S. Food and Drug Administration
Appointed Andrew Gengos as Chief Financial Officer and Chief Business Officer
Maintains
8-K
EX-99.1
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
started his career as a Technology Associate at Morgan Stanley before moving on to McKinsey & Co., where he advanced from associate to Senior Engagement
8-K
EX-3.1
me9cpc28w4jgic
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DFAN14A
EX-99.1
vb7smro
12 May 22
Additional proxy materials by non-management
2:06pm
DFAN14A
EX-99.1
ne41iq
27 Apr 22
Additional proxy materials by non-management
2:39pm
DEFC14A
gysi6oqk
11 Apr 22
Proxy in contested solicitation
8:36am
PREC14A
l8xoc c3ojb0l
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
DEFA14A
eb4wtf0q
5 Apr 22
Additional proxy soliciting materials
5:03pm
DEFC14A
jvwsxm4
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
0qhxdfpln47zq
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DFAN14A
i5ucy pgeye
30 Mar 22
Additional proxy materials by non-management
10:21am
PREC14A
k4f 22o6btku4l2
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
DEF 14A
vr61dv6bu8860vig
16 Apr 21
Definitive proxy
6:02am
10-K
ayab99n3f61s8y8 s8tj
25 Mar 21
Annual report
12:00am
424B4
6zb7zyye1kk90gt8v
21 Jan 21
Prospectus supplement with pricing info
12:00am